Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Enemona E. Adaji
Eli Lilly and Company
Poster(s):
(004) Challenges of multi-country post-authorisation safety studies for surveillance of new medical products
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(281) Progress Towards Enrollment in a US Pregnancy Registry for Galcanezumab and Lasmiditan
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
